Analyst Ratings for Puma Biotechnology (PBYI) [Sells]
PBYI Rating Summary
PBYI Price Target Summary
- Highest: $4.00 (TD Cowen)
- Lowest: $4.00 (TD Cowen)
- Average: $4.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$4.00 (-17.2%)
* Over Last 12-Mos
Rating Score: 3.3 / 10 Percentile Rank: 30%
Rating Score: 3.3 / 10 Percentile Rank: 30%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
6/25/2020 | BofA Securities | Ying Huang | New Coverage | Underperform (N/A) |
9.00 (N/A) |
11.39 (4.83) |
-57.59% | Details |
10/8/2019 | Goldman Sachs » Updated 11/5/2021 |
Paul Choi | Downgrade | Sell (Neutral) |
7.00 (8.00) |
10.01 (4.83) |
-51.75% | Details |